In this Leaflet we would like to inform you on the progress of this project and to thank all the patients who agreed to take part in the REQUITE study. The Leaflet is available in English, Spanish, French, German, Italian and Dutch.
Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality of Life in Cancer Survivors
El propósito de este estudio internacional es tratar de predecir qué pacientes son más propensos a desarrollar efectos adversos tras la radioterapia
- The first day of the Final REQUITE Symposium (17th July, 8:30-17:30, CityLabs) was open to REQUITE consortium me
The Radiogenomics Consortium (RGC) and REQUITE Consortium meetings are taking place in Manchester in July 2018.
The 24th Annual Meeting of the German Society for Radiation Oncology, Deutschen Gesellschaft fur Radioonkologie (DEGRO), is organized by MCI Deutschland GmbH and will be held during Jun 21 - 24, 2018 at Congress Center Leipzig in Germany. The target audience for this medical event is Radiation Oncologists and Oncologists.
ESMO is and continues to be a leading force of high-quality oncology education, a platform for immense international visibility for scientific research, and a proud contributor to continuous improvements in patient care.
For more information: website
ASTRO’S Annual Meeting is the premier radiation oncology scientific event in the world and draws more than 11,000 attendees each year.
Abstract Submission Site Opens: December 13, 2017
Abstract Submission Site Closes: February 14, 2018